Safrin, S <br/><br/>
Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  May 1993 
 - 975-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.37.5.975  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--administration & dosage<br/>Administration, Topical<br/>Antiviral Agents--administration & dosage<br/>Drug Resistance, Microbial<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--complications<br/>Herpes Genitalis--complications<br/>Humans<br/>Hydrazones--administration & dosage<br/>Male<br/>Pyridines--administration & dosage<br/>Ribonucleotide Reductases--antagonists & inhibitors<br/>Simplexvirus--drug effects